Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121147243 | 12114724 | 3 | F | 20151209 | 20160825 | 20160225 | 20160830 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-091942 | BRISTOL MYERS SQUIBB | 73.88 | YR | M | Y | 0.00000 | 20160830 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121147243 | 12114724 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | 5 MG, QD | 460 | MG | 202155 | 5 | MG | FILM-COATED TABLET | QD | ||||
121147243 | 12114724 | 2 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 6900 | MG | 0 | 75 | MG | QD | |||||
121147243 | 12114724 | 3 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 10 MG, QD | 860 | MG | U | 0 | 10 | MG | TABLET | QD | |||
121147243 | 12114724 | 4 | C | SELARA | EPLERENONE | 1 | Oral | 25 MG, QD | 2150 | MG | U | 0 | 25 | MG | TABLET | QD | |||
121147243 | 12114724 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | 3440 | MG | U | 0 | 40 | MG | TABLET | QD | |||
121147243 | 12114724 | 6 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 20 MG, QD | 1720 | MG | U | 0 | 20 | MG | TABLET | QD | |||
121147243 | 12114724 | 7 | C | BROTIZOLAM | BROTIZOLAM | 1 | Oral | 0.25 MG, QD | 21.5 | MG | U | 0 | .25 | MG | TABLET | QD | |||
121147243 | 12114724 | 8 | C | DESYREL | TRAZODONE HYDROCHLORIDE | 1 | Oral | 25 MG, QD | 2150 | MG | U | 0 | 25 | MG | TABLET | QD | |||
121147243 | 12114724 | 9 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 10 MG, BID | 1720 | MG | U | 0 | 10 | MG | TABLET | BID | |||
121147243 | 12114724 | 10 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | 6450 | MG | U | 0 | 75 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121147243 | 12114724 | 1 | Cerebrovascular accident prophylaxis |
121147243 | 12114724 | 2 | Product used for unknown indication |
121147243 | 12114724 | 3 | Prophylaxis |
121147243 | 12114724 | 4 | Product used for unknown indication |
121147243 | 12114724 | 5 | Product used for unknown indication |
121147243 | 12114724 | 6 | Prophylaxis |
121147243 | 12114724 | 7 | Prophylaxis |
121147243 | 12114724 | 8 | Prophylaxis |
121147243 | 12114724 | 9 | Product used for unknown indication |
121147243 | 12114724 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121147243 | 12114724 | HO |
121147243 | 12114724 | DE |
121147243 | 12114724 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121147243 | 12114724 | Cardiac failure | |
121147243 | 12114724 | Contraindicated product administered | |
121147243 | 12114724 | Lower gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121147243 | 12114724 | 1 | 20150915 | 20151215 | 0 | |
121147243 | 12114724 | 2 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 3 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 4 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 5 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 6 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 7 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 8 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 9 | 20150915 | 20151216 | 0 | |
121147243 | 12114724 | 10 | 20150915 | 20151215 | 0 |